Noven Pharmaceuticals, Inc. FDA Inspection Record
Noven Pharmaceuticals, Inc. is an FDA-registered facility (FEI 1000222037) located in Miami, FL, US. Registered operations: ANALYSIS; LABEL; MANUFACTURE; PACK. RegDataLab tracks 9 FDA inspections and 1 compliance action at this facility.
What FDA found at this site
- Latest inspection
- Aug 24, 2026: Voluntary Action Indicated (VAI)
- Inspections on record
- 9 (1 OAI, 4 VAI, 4 NAI)
- Last OAI inspection
- Jul 10, 2015
- Warning letters
- 1 listed by FDA for this FEI, latest Aug 5, 2016
- Recalls as the recalling firm
- 24, latest Oct 31, 2024
- Import refusals
- 2
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Aug 24, 2026 | Voluntary Action Indicated (VAI) | Backup file not maintained (21 CFR 211.68(b)) input/output verification (21 CFR 211.68(b)) Identity Testing of Each Component (21 CFR 211.84(d)(1)) Second person sign off (21 CFR 211.194(a)(8)) |
| Feb 13, 2026 | No Action Indicated (NAI) | No citations listed |
| Nov 17, 2021 | Voluntary Action Indicated (VAI) | No citations listed |
| Jan 26, 2018 | Voluntary Action Indicated (VAI) | No citations listed |
| Jul 10, 2015 | Official Action Indicated (OAI) | No citations listed |
| Sep 24, 2012 | No Action Indicated (NAI) | No citations listed |
| Jun 4, 2012 | No Action Indicated (NAI) | No citations listed |
| May 6, 2010 | Voluntary Action Indicated (VAI) | Written procedures not established/followed (21 CFR 211.67(b)) Calibration/Inspection/Checking not done (21 CFR 211.68(a)) Absence of Written Procedures (21 CFR 211.100(a)) Procedures To Be in Writing (21 CFR 211.80(a)) and 2 more |
| Feb 6, 2009 | No Action Indicated (NAI) | Procedures not in writing, fully followed (21 CFR 211.22(d)) Absence of Written Procedures (21 CFR 211.100(a)) Investigations of discrepancies, failures (21 CFR 211.192) Complaint Handling Procedure (21 CFR 211.198(a)) and 5 more |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Oct 31, 2024 | Class II | D-0055-2025 | Xelstrym (dextroamphetamine) transdermal system, 13.5 mg dextroamphetamine/9 hours, 30… Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive). |
| Mar 10, 2023 | Class II | D-0470-2023 | Daytrana (methylphenidate transdermal system) CII, 10mg, 30-count carton, Rx only… and 3 more products Defective Delivery System: Out of specification for shear. |
| Nov 16, 2022 | Class II | D-0071-2023 | Daytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours, (1.6 mg/hr)… Defective Delivery System: Recalled lot was found to be out of specification for shear. Shear is an attribute related to the adhesive… |
| Jun 24, 2022 | Class II | D-1169-2022 | Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr)… Defective Delivery System: Customer complaints received for ripping patches and tight release/adhesive transfer. |
| May 6, 2022 | Class II | D-0889-2022 | Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr)… Defective Delivery System: customer complaints exceeded respective action limits. |
| Jul 30, 2021 | Class II | D-0724-2021 | Combipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.14 mg per day… and 1 more product Failed Stability Specifications; out of specification for shear. |
| May 20, 2021 | Class II | D-0393-2021 | Daytrana (methylphenidate transdermal system), Delivers 10 mg over 9 hours (1.1 mg/hr), 30… and 1 more product Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the… |
| Apr 16, 2021 | Class II | D-0336-2021 | Minivelle (estradiol transdermal system) Delivers 0.075 mg/day, 8 patches/box, Rx only… and 1 more product Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the… |
| Feb 19, 2021 | Class II | D-0293-2021 | Daytrana (methylphenidate transdermal system), Delivers 10 mg over 9 hours (1.1 mg/hr)… and 3 more products Defective Delivery System: Out of specification for mechanical peel. |
| Mar 31, 2020 | Class II | D-1247-2020 | Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr)… and 2 more products Defective Delivery System: Out of specification for mechanical peel and shear. |
FDA record score
33 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
29 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified VAI | Aug 24, 2026 | 6 x 1 | 6 |
| Inspection classified VAI | Nov 17, 2021 | 6 x 0.6 | 3.6 |
| Class II recall D-0055-2025, this FEI as the recalling firm | Oct 31, 2024 | 4 x 0.6 | 2.4 |
| Class II recall D-0470-2023, this FEI as the recalling firm | Mar 10, 2023 | 4 x 0.6 | 2.4 |
| Class II recall D-0071-2023, this FEI as the recalling firm | Nov 16, 2022 | 4 x 0.6 | 2.4 |
| Class II recall D-1169-2022, this FEI as the recalling firm | Jun 24, 2022 | 4 x 0.6 | 2.4 |
| Class II recall D-0889-2022, this FEI as the recalling firm | May 6, 2022 | 4 x 0.6 | 2.4 |
| Inspection classified VAI | Jan 26, 2018 | 6 x 0.25 | 1.5 |
| Class II recall D-0724-2021, this FEI as the recalling firm | Jul 30, 2021 | 4 x 0.25 | 1 |
| Class II recall D-0393-2021, this FEI as the recalling firm | May 20, 2021 | 4 x 0.25 | 1 |
| Class II recall D-0336-2021, this FEI as the recalling firm | Apr 16, 2021 | 4 x 0.25 | 1 |
| Class II recall D-0293-2021, this FEI as the recalling firm | Feb 19, 2021 | 4 x 0.25 | 1 |
| Class II recall D-1247-2020, this FEI as the recalling firm | Mar 31, 2020 | 4 x 0.25 | 1 |
| Class II recall D-1042-2020, this FEI as the recalling firm | Mar 2, 2020 | 4 x 0.25 | 1 |
| Class II recall D-1207-2018, this FEI as the recalling firm | Sep 7, 2018 | 4 x 0.25 | 1 |
| Class II recall D-0862-2018, this FEI as the recalling firm | May 4, 2018 | 4 x 0.25 | 1 |
| Class II recall D-0627-2018, this FEI as the recalling firm | Apr 9, 2018 | 4 x 0.25 | 1 |
| Class II recall D-1169-2017, this FEI as the recalling firm | Aug 30, 2017 | 4 x 0.25 | 1 |
| Class II recall D-0428-2017, this FEI as the recalling firm | Aug 22, 2016 | 10 years or older, so it adds no points | 0 |
| Warning letter on FDA's dashboard, which does not show close-outs | Aug 5, 2016 | 10 years or older, so it adds no points | 0 |
| Class II recall D-1438-2016, this FEI as the recalling firm | Dec 21, 2015 | 10 years or older, so it adds no points | 0 |
| Class II recall D-0008-2016, this FEI as the recalling firm | Jul 27, 2015 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | Jul 10, 2015 | 10 years or older, so it adds no points | 0 |
| Class II recall D-1608-2014, this FEI as the recalling firm | Jul 15, 2014 | 10 years or older, so it adds no points | 0 |
| Class II recall D-1171-2014, this FEI as the recalling firm | Feb 13, 2014 | 10 years or older, so it adds no points | 0 |
| Class II recall D-312-2013, this FEI as the recalling firm | Jan 31, 2013 | 10 years or older, so it adds no points | 0 |
| Class II recall D-1653-2012, this FEI as the recalling firm | Jul 12, 2012 | 10 years or older, so it adds no points | 0 |
| Class II recall D-1413-2012, this FEI as the recalling firm | Mar 22, 2012 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | May 6, 2010 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Inspection citations | Nov 17, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 17, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 17, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 17, 2026 | Newest record Nov 16, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing Noven Pharmaceuticals, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Noven Pharmaceuticals, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Noven Pharmaceuticals, Inc.
- Location
- Miami, FL (US)
- Registration Expires
- Dec 31, 2027
- Operations
- ANALYSIS; LABEL; MANUFACTURE; PACK
- Source
- decrs